Rich Jones

Rich Jones currently serves as VP and Head of Global Business Strategy & Analytics at Daiichi Sankyo, Inc., leading teams involved in Market Research, Forecasting, Pipeline Strategy, Competitive Intelligence, and Investor Relations within the Global Oncology Business Unit since June 2021. Prior to this role, Rich Jones was the US Hematology BIA Lead at Bristol Myers Squibb, overseeing a team managing analytics for a portfolio exceeding $14 billion. Previously, Rich Jones held the position of Division CFO at Celgene, where responsibilities included business planning and financial operations, and served as Senior Director of the Commercial Assessment Team at Daiichi Sankyo, focusing on business development and portfolio management. Rich Jones also gained experience in strategy and operations at Novartis. Rich Jones holds a BS in Pharmacy from Northeastern University and an MBA in Finance from Seton Hall University, along with executive education from Columbia University and Harvard University.